  See all
 |
Articles: Major Studies |
Sanofi-aventis and Regeneron Announce Results from Phase 2 Study with Aflibercept (VEGF Trap) in Advanced Ovarian Cancer with Recurrent Symptomatic
Malignant Ascites
Sanofi-aventis, 06/12/09
Free full text
New study results further support the efficacy and safety of a once daily Mirapexin/Sifrol (pramipexole) formulation at all stages of Parkinson`s disease, with added benefits in the reduction of off-time
Boehringer Ingelheim, 06/11/09
Free full text
Recruitment completed in zalutumumab head and neck cancer pivotal study
Genmab, 06/11/09
Free full text
Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study
BioMarin, 06/10/09
Free full text
Abbott's TRILIPIX (fenofibric acid) in Combination with Rosuvastatin Calcium Helps Patients with Mixed Dyslipidemia and Type 2 Diabetes Meet American Diabetes Association Lipid Targets
Abbott, 06/09/09 Study shows GSK's novel diabetes treatment Syncria (albiglutide) improves glucose control and reduces weight
GlaxoSmithKline, 06/09/09
Free full text
Active Biotech Completes Patient Enrollment to TASQ Clinical Phase II study
Active Biotech, 06/09/09
Free full text
Fyi from human genome sciences: glaxosmithkline study shows gsk's novel diabetes treatment syncria (albiglutide) improves glucose control, reduces weight
Human Genome Sciences, 06/09/09
Free full text
Dapagliflozin Study Demonstrated Improved Glycemic Control In Type 2 Diabetes Patients Treated With High Doses of Insulin and Common Oral Anti-Diabetic Medicines
Bristol Myers-Squibb Company, 06/08/09
Free full text
New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate and Treatment Failure in Patients With Chronic ITP
Amgen, 06/08/09
Free full text
Actemra (tocilizumab) studies to be featured at the european league against rheumatism (eular) congress
Roche, 06/05/09
Free full text
AstraZeneca studies show relief of nighttime heartburn and reduction in GERD-related sleep disturbances
AstraZeneca, 06/04/09
Free full text
Impact study showed longer valcyte (valganciclovir hydrochloride tablets) treatment demonstrated better protection against cytomegalovirus (cmv) disease one year post-transplant
Roche, 06/04/09
Free full text
Cytokinetics Presents Clinical Data Relating To Ispinesib in Patients with Metastatic Breast Cancer at the 2009 Annual Meeting of the American Society of Clinical Oncology
Cytokinetics, 06/03/09
Free full text
GSKs Pazopanib significantly delayed tumor progression in patients with advanced kidney cancer
GlaxoSmithKline, 06/02/09
Free full text
Positive Results from Salix Pivotal Phase III Study of Rifaximin for the Prevention and Maintenance of Remission of Hepatic Encephalopathy (HE) Presented at Digestive Disease Week
Salix Pharmaceuticals, 06/02/09
Free full text
Phase III study data with vandetanib (ZACTIMA) in patients with advanced non-small cell lung cancer (NSCLC) presented at American Society of Clinical Oncology
AstraZeneca, 06/01/09
Free full text
Results from Three Phase 2 Studies Reported a Two-Year Survival Rate Ranging from 30 to 42 Percent in Metastatic Melanoma Patients Treated with Ipilimumab
Bristol Myers-Squibb Company, 06/01/09
Free full text
Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
Forest Laboratories, 06/01/09
Free full text
Additional data confirm clopidogrel-PPI interaction
American Pharmacists Association, 05/29/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
171 Available Pages
|
|
